PLI PLUS 2.0 is now available – click
here
to test drive the new platform.
Skip to main content
Create Account
Training Center
Contact Us
Questions? Comments?
Contact us.
Email:
PLUS@pli.edu
Phone:
877.900.5291
PLI.edu
SIGN IN
Search
Browse
All Content
Books
- Answer Books
- Course Handbooks
- Journals
- Insights
- Treatises
Forms & Checklists
Transcripts
My Bookshelf
My History
< Back To Results
1 in 13651 results
Previous Result
Next Result
Health Care Law Institute 2015
Chair(s):
David J. Farber, Esther Scherb
Practice Area:
Health care,
Health insurance,
Insurance,
Insurance products,
Life sciences,
Pharmaceuticals
Published:
Nov 2015
i
Other versions can be found in the
Related Items
tab.
ISBN:
9781402425677
PLI Item #:
147400
CHB Spine #:
M8
This version is not current.
Click here for the most recent version.
Search
Email
Print
Add To Bookshelf
Permalink
Table of Contents
Related Items
Select All
Front Matter
Faculty Bios
Table of Contents
Chapter 1. Reimbursement Policies for Biosimilars (September 4, 2015)
Chapter 2. CMS MLN Matters® Number: SE1509, Food and Drug Administration Approval of First Biosimilar Product (March 2015)
Chapter 3. The Future Cost of Innovation: An Analysis of the Impact of Breakthrough Therapies on Government Spending (June 2015)
Chapter 4. Medicare Advantage: 2015 National Snapshot (July 2015)
Chapter 5. Clinical Pathways: Overview of Current Practices and Potential Implications for Patients, Payers, and Providers (July 2015)
Chapter 6. Providers Rush to Assume Medicare Risk under Bundled Payment Program: Orthopedic, Pulmonary, and Cardiovascular Conditions Most Likely To Be Treated under CMS Bundled Payment Program
Chapter 7. New Market Entrants: Growth and Diversification in U.S. Health Insurance (September 2015)
Chapter 8. More than 2 Million Exchange Enrollees Forgo Cost-Sharing Assistance
Chapter 9. Excerpt: Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2016: Proposed Rule by the Centers for Medicare & Medicaid Services on 07/15/2015
Chapter 10. Department of Health and Human Services, Centers for Medicare & Medicaid Services, Medicare Program; Medicare Shared Savings Program: Accountable Care Organizations; Final Rule, 76 F.R. 212, Wednesday, November 2, 2011, Part III
Chapter 11. Financial Models to Support State Efforts to Integrate Care for Medicare-Medicaid Enrollees
Chapter 12. Current Enforcements Trends in Healthcare (PowerPoint slides)
Chapter 13. 2015 Mid-Year FDA and Health Care Compliance and Enforcement Update—Drugs and Devices
Chapter 14. Developing Mixed-Source Commercial Products: Open Source Software Risks and Mitigation
Chapter 15. Compliance Programs and Investigations (PowerPoint slides)
Chapter 16. Practical Guidance for Health Care Governing Boards on Compliance Oversight
Chapter 17. Updated: OIG’s Provider Self-Disclosure Protocol
Chapter 18. Department of Health and Human Services, Office of Inspector General, Publication of OIG Compliance Program Guidance for Clinical Laboratories
Chapter 19. CMS Voluntary Self-Referral Disclosure Protocol
Chapter 20. Department of Health and Human Services, Office of Inspector General, Publication of the OIG Compliance Program Guidance for Hospitals
Chapter 21. Department of Health and Human Services, Office of Inspector General, OIG Supplemental Compliance Program Guidance for Hospitals
Chapter 22. 21st Century Cures Act: Key Provisions Related to Drugs (August 7, 2015)
Chapter 23. 21st Century Cures Act: Key Provisions Related to Medical Devices (July 30, 2015)
Index
About Us